Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma
The ADAPT study will evaluate the safety and effectiveness of the company’s Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
The ADAPT study will evaluate the safety and effectiveness of the company’s Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System